Cell therapy starting material varies significantly, presenting challenges in maintaining a standardized and reproducible manufacturing process. With the r...

Looking to streamline your CAR T cell process? Discover how lipid nanoparticles (LNP) deliver base editing tools to generate fratricide-resistant CD45-edit...

Delivering nucleic acids using lipid nanoparticles (LNP) to target cells has tremendous potential to enable new cell and gene therapies. In this webinar, w...

Register for this webinar to: learn how to improve the quality of our results, view the AKTA oligosynt™ synthesizer and find out how it can maximize your o...

Register for this webinar to: learn about the oligo therapeutic market, gain insight on the challenges you may face when bringing your process in house and...

Register for this webinar to: learn about the complete oligo workflow from Cytiva, find out what reagents are available and how these are optimized for use...

CAR T therapies are gaining increased attention due to their demonstrated potential in patient outcomes. For a successful commercialization of these therap...

Reduce operator-derived errors with the help of Sefia™ platform. Keep an eye on how everything is going: the system’s functionally closed design and automa...

According to data from our 2023 Global Biopharma Resilience Index, 55% of pharma leaders are happy with the speed of drug approvals — meaning 45% feel ther...

Learn all about Fast Trak™ services from Cytiva from our very own Fast Trak™ Global Technical Leader, Sabrina Carmichael. In this video, you’ll get an over...